京新药业：2025年上半年净利润3.88亿元，同比下降3.54%

Group 1 - The company reported a revenue of 2.017 billion yuan for the first half of 2025, representing a year-on-year decline of 6.20% [1] - The net profit for the same period was 388 million yuan, showing a year-on-year decrease of 3.54% [1] - The company announced plans not to distribute cash dividends, issue bonus shares, or increase share capital from reserves [1]